Literature DB >> 2137781

Monoclonal antibodies reacting with the interleukin 1 receptor define a multi-molecular complex.

C Lewis1, G Mazzei, A Shaw.   

Abstract

By sequential immunization with a variety of different interleukin (IL) 1 receptor (IL 1R)-bearing cells and by generating a large number of clones from a single fusion experiment, we have managed to produce two monoclonal antibodies which react with the lymphocyte IL 1R. The antibodies also react with the mouse fibroblast line, 3T3, but we have not yet defined their reactivity with cells carrying low-affinity receptors. Immunoprecipitation allows the IL 1R to be isolated from EL4 6.1 cell membrane preparations and shows that the IL 1R exists as a complex. The antibodies clearly interfere with IL 1 responses both in vitro and in vivo. These are the first anti-mouse IL 1R antibodies to be described which clearly and profoundly affect the immune response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137781     DOI: 10.1002/eji.1830200130

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Cytosolic domain of the type I interleukin-1 receptor spontaneously recruits signaling molecules to activate a proinflammatory gene.

Authors:  R Singh; S Huang; T Guth; M Konieczkowski; J R Sedor
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

2.  Interleukin-4 inhibits secretion of interleukin-1beta in the response of human cells to mycobacterial heat shock proteins.

Authors:  P Méndez-Samperio; A Badillo-Flores; A Nuñez-Vazquez; M Hernandez Garay
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

3.  Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells.

Authors:  P Conti; C Feliciani; R C Barbacane; M R Panara; M Reale; F C Placido; D N Sauder; R A Dempsey; P Amerio
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.